# Aperion Biologics, Inc. — Form D

Aperion Biologics, Inc. of San Antonio, TX, a company, filed a Form D exempt-offering notice with the SEC on 2011-05-31. The offering totals $6.0M, of which $4.5M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2011-05-31
- Form: D
- Accession: 0001439026-11-000004
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $6.0M
- Amount sold: $4.5M
- Remaining: $1.5M
- Investors: 1
- Date of first sale: 2011-05-20
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-160541

## Issuer

- Name: Aperion Biologics, Inc.
- CIK: 0001439026
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2008
- Address: 11969 Starcrest Drive, San Antonio, TX, 78247
- Phone: 210.858.7070

## Officers, directors & promoters (6)

| Name | Role | Location |
| --- | --- | --- |
| Al T Holcomb | Director | San Antonio, TX |
| Daniel R Lee | Director | Las Vegas, NV |
| Dugan R Schwalm | Director | San Antonio, TX |
| Kevin R Stone | Director | San Antonio, TX |
| William T White III | Director | Durham, NC |
| Daniel R Lee | Executive Officer | Las Vegas, NV |

## More

- [CIK 1439026 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1439026&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001439026-11-000004.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.